This is a non-core endpoint: only basic statistics are computed.
Retinoblastoma (controls excluding all cancers)
C3_RETINOBLAST_EXALLC
No definition available.
Endpoint definition
↥
FinnGen phenotype data
individuals
Apply sex-specific rule None
Check conditions None
Check pre-conditions, main-only, mode, registry filters
Cancer registry: Topography ICD-O-3
C69
Cancer registry: Morphology ICD-O-3
951[0-4]
Cancer registry: Behaviour codes
3
2 out of 7 registries used, show all original rules.
-
Check minimum number of events None
-
Include endpoints None
-
Remove individuals based on genotype QC
24
C3_RETINOBLAST_EXALLC
Control definitions
Control exclude
C3_CANCER, C3_CANCER_WIDE
Extra metadata
First used in FinnGen datafreeze
DF8
No upset plot: script not run.
No upset table: script not run.
Similar endpoints
↥List of similar endpoints to
Retinoblastoma (controls excluding all cancers)
based on the number of shared cases.
Broader endpoints:
- Retinoblastoma
- Malignant neoplasm of eye and adnexa (controls excluding all cancers)
- Malignant neoplasm of eye and adnexa
- Malignant neoplasm of eye, brain and central nervous system
- Malignant neoplasm of eye, brain and central nervous system (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 24 | 13 | 11 |
| Unadjusted prevalence (%) | 0.01 | 0.01 | 0.01 |
| Mean age at first event (years) | 5.03 | 7.38 | 2.26 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_RETINOBLAST_EXALLC – Retinoblastoma (controls excluding all cancers)
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Retinoblastoma (controls excluding all cancers)
↥Endpoint not on priority list, no data to show.